Testing effectiveness (Phase 2)Study completedNCT03922321
What this trial is testing
Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)
Who this might be right for
Graves' Ophthalmopathy
Immunovant Sciences GmbH 7